Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

906

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

906 results for “atherosclerosis”

Learn how ShareScore rates datasets ↗
zenodo52/100

Reference percentiles for carotid measures of subclinical atherosclerosis in children and adolescents – Data from the KiGGS study

<p>The dataset presents reference centile data for carotid intima-media thickness as well as four carotid stiffness parameters. The reference percentiles are based on data from the German Health Interview and Examination Survey for Children and Adolescents 2003-2006 (KiGGS). KiGGS started as a cross-sectional study conducted between 2003 and 2006 which was based on a nationally representative sample and aimed at obtaining comprehensive data on the health of children and adolescents aged 0 to 17 years living in Germany. Detailed information on study design and conduct has been published in peer reviewed journals as well as detailed papers on individual parameters. The documentation provides relevant references.<br> <br> 11 years later, KiGGS Wave 2 (2014-2017) was conducted as an interview and examination survey. Carotid sonography was attempted at follow-up (KiGGS2) in all 4,798 participants of the KiGGS cohort aged 14 to 28 years. Carotid intima-media thickness (CIMT) was successfully measured in 4,709 participants. Reference centiles for the distensibility coefficient, stiffness index &szlig;, Young&#39;s elastic modulus and Peterson&#39;s elastic modulus were computed using data on 4,305 adolescents and young adults aged 14 to 28.</p>

opencc-by-4.0Sep 2022View details →
zenodo44/100

GWAS to single cell: Intersecting single-cell transcriptomics and genome wide association studies identifies crucial cell-populations and candidate genes for atherosclerosis.

<p><strong>Background</strong></p> <p>Genome-wide association studies (GWAS) have discovered hundreds of common genetic variants for atherosclerotic disease and cardiovascular risk factors. The translation of susceptibility loci into biological mechanisms and targets for drug discovery remains challenging. Intersecting genetic and gene expression data has led to identification of candidate genes. However, the assayed tissues are often non-diseased and heterogeneous in cell composition confounding the candidate prioritization. We collected single-cell transcriptomics (scRNA-seq) from atherosclerotic plaques and aimed to identify cell-type-specific expression of disease-associated genes.&nbsp;</p> <p>&nbsp;</p> <p><strong>Methods and Results</strong></p> <p>To identify disease-associated candidate genes, we applied gene-based analyses using GWAS summary statistics from 46 atherosclerotic, cardiometabolic, and other traits. Next we intersected these candidates with single-cell transcriptomics (scRNA-seq) to identify those genes that are specifically expressed in individual cell (sub)populations of atherosclerotic plaques. We derive an enrichment score and show that loci that associated with coronary artery disease demonstrated a prominent substrate in plaque smooth muscle cells (<em>SKI</em>, <em>KANK2</em>, <em>SORT1</em>), endothelial cells (<em>SLC44A1</em>, <em>ATP2B1</em>), and macrophages (<em>APOE</em>, <em>HNRNPUL1</em>). Further sub clustering of SMC-subtypes revealed genes in risk loci for coronary calcification specifically enriched in a synthetic cluster of SMCs. To verify the robustness of our approach, we used liver-derived scRNAseq-data and showed enrichment of circulating lipids-associated loci in hepatocytes.</p> <p><br> <strong>Conclusion</strong></p> <p>We confirm known gene-cell pairs relevant for atherosclerotic disease, and discovered novel pairs pointing to new biological mechanisms amenable for therapy. We present an intuitive single-cell transcriptomics driven workflow rooted in human large-scale genetic studies to identify putative candidate genes and affected cells associated with cardiovascular traits.</p> <p>&nbsp;</p>

opencc-by-4.0May 2021View details →
zenodo40/100

Time to run: Late rather than early exercise training in mice promotes fat mass loss and reduces atherosclerosis development

<p>This dataset contains forward and reverse reads of 16S&nbsp;sequencing of&nbsp;the V3-V4 region of caecal bacteria. As indicated in the metadata file, mice are divided into three groups - SED (sedentary mice, E-SED for early sedentary and L-SED for late sedentary), E-RUN (early runners) and L-RUN (late runners). For more information about the groups, sequencing etc., consult the manuscript.</p>

opencc-by-4.0Aug 2022View details →
zenodo40/100

Research data supporting "Raman spectroscopy imaging reveals interplay between atherosclerosis and medial calcification in human aorta"

<p>Research data supporting the publication:</p> <p>You, A. Y.&nbsp; F. <em>et al.</em>, 2017, &quot;Raman spectroscopy imaging reveals interplay between atherosclerosis and medial calcification in human aorta&quot;, Science Advances, DOI: 10.1126/sciadv.1701156.</p>

opencc-by-4.0Dec 2017View details →
zenodo36/100

Bioactive compounds from Crataegus Oxycantha Protects myocardium against important proteins of atherosclerosis. An in-depth analysis using molecular simulation studies

<p>We are submitting this data as a raw file for the submission of our manuscript to the peer reviwed journals.&nbsp;</p>

opencc-by-4.0Mar 2024View details →
zenodo36/100

Summary Statistics from "Genome-wide meta-analysis of phytosterols reveals five novel loci and a detrimental effect on coronary atherosclerosis"

<p>Summary statistics of meta GWAS of phytosterols.</p>

opencc-by-4.0Oct 2021View details →
zenodo36/100

YB1 dephosphorylation attenuates atherosclerosis by promoting CCL2 mRNA decay

<p>&nbsp;Y-box binding protein 1 (YB1) is an RNA binding protein (RBP) that has been reported to play important roles in inflammation and atherosclerotic plaque formation.&nbsp;To explore the molecular mechanism of phosphorylated YB1 (pYB1)&nbsp;in atherosclerosis <em>in vitro</em>, we constructed YB1 phosphorylation site (Ser-100) mutant stable smooth muscle cell line (3ds-V5) and performed RNA profile screening through RNA-seq.&nbsp; We found inflammatory pathways and&nbsp;CCL2 was&nbsp;significantly decreased in the 3dS-V5 YB1 mutant compared with the control group (YB1-V5).</p>

opencc-by-4.0Jul 2022View details →
zenodo36/100

THOR progress presentation 2022: Targeting Smooth Muscle Cells for Atherosclerosis Therapy

<p>This is a recorded talk with head of the THOR project - Jacob Fog Bentzon, where he presents the latest project progress.</p> <p>The talk was given at one of ODIN&#39;s (the Open Discovery Innovation Network) Knowledge Sharing Events in May 2022.</p>

opencc-by-4.0May 2022View details →
zenodo36/100

Encompassing view of spatial and single-cell RNA-seq renews the role of the microvasculature in human atherosclerosis

<p>Here we generate an integrative high-resolution map of human atherosclerotic plaques combining single-cell RNA-seq from multiple studies and spatial transcriptomics data from 12 human specimens, with different stages of atherosclerosis. We show cell-type and atherosclerosis-specific expression changes and spatially constrained alterations in cell-cell communication.</p>

opencc-by-4.0Oct 2024View details →
ClinicalTrials.gov36/100

Rilonacept to Improve Artery Function in Patients With Atherosclerosis

ClinicalTrials.gov study NCT00417417. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of Atorvastatin on Atherosclerosis Composition

ClinicalTrials.gov study NCT00576576. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans

ClinicalTrials.gov study NCT01067339. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Preventive Effects of Ginseng Against Atherosclerosis

ClinicalTrials.gov study NCT02796664. IPD Sharing: NO. Countries: 1. Publications: 10.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis

ClinicalTrials.gov study NCT00886704. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Effect of Evolocumab on Coronary Atherosclerosis

ClinicalTrials.gov study NCT03689946. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease

ClinicalTrials.gov study NCT03011775. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

ClinicalTrials.gov study NCT07307989. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis

ClinicalTrials.gov study NCT04410003. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Does Rosuvastatin Delay Progression of Atherosclerosis in HIV

ClinicalTrials.gov study NCT01813357. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

ClinicalTrials.gov study NCT00608062. IPD Sharing: NO. Countries: 1. Publications: 8.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record